{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:19:58Z","timestamp":1793020798208,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","award":["459461\/2014-1"],"award-info":[{"award-number":["459461\/2014-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/01565-8"],"award-info":[{"award-number":["2019\/01565-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/07501-9"],"award-info":[{"award-number":["2018\/07501-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.japh.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T11:24:12Z","timestamp":1649935452000},"page":"1463-1476.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cost of adverse drug events related to potentially inappropriate medication use: A systematic review"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-6155","authenticated-orcid":false,"given":"Geovana","family":"Schiavo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-8519","authenticated-orcid":false,"given":"Marcela","family":"Forgerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-1320","authenticated-orcid":false,"given":"Rosa C.","family":"Lucchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9056-2987","authenticated-orcid":false,"given":"Gustavo O.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7278","authenticated-orcid":false,"given":"Patr\u00edcia d.C.","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.japh.2022.04.008_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jamda.2016.11.025","article-title":"The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality: a systematic review and meta-analysis of cohort studies","volume":"18","author":"Muhlack","year":"2017","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"10","key":"10.1016\/j.japh.2022.04.008_bib2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/MLR.0000000000000587","article-title":"A\u00a0systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults","volume":"54","author":"Hyttinen","year":"2016","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.japh.2022.04.008_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/1060028019853069","article-title":"Associations between potentially inappropriate medications and adverse health outcomes in the elderly: a systematic review and meta-analysis","volume":"53","author":"Xing","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.japh.2022.04.008_bib4","doi-asserted-by":"crossref","DOI":"10.17533\/udea.vitae.v27n3a02","article-title":"Drug interactions for elderly with respiratory disorders and times of COVID-19: a systematic scoping review","volume":"27","author":"Forgerini","year":"2020","journal-title":"Vitae"},{"key":"10.1016\/j.japh.2022.04.008_bib5","doi-asserted-by":"crossref","first-page":"104283","DOI":"10.1016\/j.archger.2020.104283","article-title":"Drug interactions for elderly people with mental and behavioral disorders: a systematic scoping review","volume":"93","author":"Forgerini","year":"2021","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.japh.2022.04.008_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vhri.2021.05.003","article-title":"A\u00a0systematic review of potentially inappropriate medications use and related costs among the elderly","volume":"25","author":"Malakouti","year":"2021","journal-title":"Value Heal Reg Issues"},{"issue":"3","key":"10.1016\/j.japh.2022.04.008_bib7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1345\/aph.1H473","article-title":"Healthcare outcomes associated with Beers\u2019 criteria: a systematic review","volume":"41","author":"Jano","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.japh.2022.04.008_bib8","doi-asserted-by":"crossref","unstructured":"Schiavo G, Forgerini M, Lucchetta RC, Mastroianni PC. A comprehensive look at explicit screening tools for potentially inappropriate medication: a systematic scoping review [e-pub ahead of print]. Australas J Ageing. February 28, 2022. https:\/\/doi.org\/10.1111\/ajag.13046, ePub ahead of print.","DOI":"10.1111\/ajag.13046"},{"key":"10.1016\/j.japh.2022.04.008_bib9","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.japh.2022.04.008_bib10","series-title":"The Joanna Briggs Institute Reviewers\u2019 Manual 2014: The Systematic Review of Economic Evaluation Evidence.","year":"2014"},{"key":"10.1016\/j.japh.2022.04.008_bib11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.japh.2022.04.008_bib12","first-page":"664","article-title":"Direct and indirect costs associated with Dupuytren\u2019s contracture","volume":"15","author":"Macaulay","year":"2012","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.japh.2022.04.008_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1590\/S0101-60832007000800012","article-title":"Estudos farmacoecon\u00f4micos e carga da doen\u00e7a em esquizofrenia","volume":"34","author":"Daltio","year":"2007","journal-title":"Arch Clin Psychiatry (S Paulo)"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"8","key":"10.1016\/j.japh.2022.04.008_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: a guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3233\/JAD-190819","article-title":"Drug-related problems increase healthcare costs for people living with dementia","volume":"73","author":"Wohlgemuth","year":"2020","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.japh.2022.04.008_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1331\/JAPhA.2009.08102","article-title":"National study of medications associated with injury in elderly Medicare\/Medicaid dual enrollees during 2003","volume":"49","author":"Blackwell","year":"2009","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s41669-019-0143-2","article-title":"The health system costs of potentially inappropriate prescribing: a population-based, retrospective cohort study using linked health administrative databases in Ontario, Canada","volume":"4","author":"Black","year":"2020","journal-title":"Pharmacoecon Open"},{"issue":"11","key":"10.1016\/j.japh.2022.04.008_bib31","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1111\/jgs.16743","article-title":"Potentially inappropriate medications are associated with increased healthcare utilization and costs","volume":"68","author":"Clark","year":"2020","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jgo.2019.01.012","article-title":"Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers","volume":"10","author":"Feng","year":"2019","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1248\/bpb.b18-00820","article-title":"Analysis of adverse reactions caused by potentially inappropriate prescriptions and related medical costs that are avoidable using the Beers criteria: the Japanese version and guidelines for medical treatment and its safety in the elderly 2015","volume":"42","author":"Tachi","year":"2019","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.japh.2022.04.008_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40266-017-0441-2","article-title":"Health service use, costs, and adverse events associated with potentially inappropriate medication in old age in Germany: retrospective matched cohort study","volume":"34","author":"Heider","year":"2017","journal-title":"Drugs Aging"},{"issue":"7","key":"10.1016\/j.japh.2022.04.008_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198004","article-title":"The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study","volume":"13","author":"Heider","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10198-018-0992-0","article-title":"The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons: a longitudinal 12-year study","volume":"20","author":"Hyttinen","year":"2019","journal-title":"Eur J Health Econ"},{"issue":"7","key":"10.1016\/j.japh.2022.04.008_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40266-017-0464-8","article-title":"Impact of 2015 update to the Beers criteria on estimates of prevalence and costs associated with potentially inappropriate use of antimuscarinics for overactive bladder","volume":"34","author":"Suehs","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.japh.2022.04.008_bib18","series-title":"Prescripci\u00f3n inapropiada en adultos mayores hospitalizados [Inappropriate prescription in elderly inpatients]. Medicina (B Aires)","first-page":"362","author":"Fajreldines","year":"2016"},{"issue":"4","key":"10.1016\/j.japh.2022.04.008_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jgs.14030","article-title":"Effect of potentially inappropriate use of antimuscarinic medications on healthcare use and cost in individuals with overactive bladder","volume":"64","author":"Suehs","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jgs.13229","article-title":"Association between potentially inappropriate medication use in elderly adults and hospital-related outcomes","volume":"63","author":"Hagstrom","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.japh.2022.04.008_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40266-015-0287-4","article-title":"Impact of inappropriate drug use on hospitalizations, mortality, and costs in older persons and persons with dementia: findings from the SNAC study","volume":"32","author":"Sk\u00f6ldunger","year":"2015","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.japh.2022.04.008_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ps.201200089","article-title":"Economic impact of inappropriate benzodiazepine prescribing and related drug interactions among elderly persons","volume":"64","author":"Dionne","year":"2013","journal-title":"Psychiatr Serv"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.amjopharm.2010.03.005","article-title":"Potentially inappropriate medication use in elderly Japanese patients","volume":"8","author":"Akazawa","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib35","first-page":"e1","article-title":"Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly","volume":"16","author":"Stockl","year":"2010","journal-title":"Am J Manag Care"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/nur.20232","article-title":"Health outcomes associated with potentially inappropriate medication use in older adults","volume":"31","author":"Fick","year":"2008","journal-title":"Res Nurs Health"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.mlr.0000254571.05722.34","article-title":"Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly","volume":"45","author":"Fu","year":"2007","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1543-5946(04)90015-3","article-title":"Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly","volume":"2","author":"Aparasu","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib20","first-page":"407","article-title":"Potentially inappropriate medication use in a medicare managed care population: association with higher costs and utilization","volume":"7","author":"Fick","year":"2001","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"6","key":"10.1016\/j.japh.2022.04.008_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00228-018-2446-0","article-title":"Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria","volume":"74","author":"Motter","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2022.04.008_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF03319105","article-title":"The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review","volume":"35","author":"Chiatti","year":"2012","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.japh.2022.04.008_bib39","first-page":"216","article-title":"Risk factors associated with drug therapy among elderly people with Alzheimer\u2019s disease: a cross-sectional study","volume":"138","author":"Forgerini","year":"2020","journal-title":"S\u00a0Paulo Med J"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12877-019-1280-2","article-title":"Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study","volume":"19","author":"Grossi","year":"2019","journal-title":"BMC Geriatr"},{"issue":"10","key":"10.1016\/j.japh.2022.04.008_bib41","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archsurg.138.10.1068","article-title":"Physiological features of aging persons","volume":"138","author":"Aalami","year":"2003","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.japh.2022.04.008_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1532-5415.2009.02131.x","article-title":"Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the aged","volume":"57","author":"Wehling","year":"2009","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"9","key":"10.1016\/j.japh.2022.04.008_bib43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1060028018765159","article-title":"Cost of prescription drug\u2013related morbidity and mortality","volume":"52","author":"Watanabe","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.japh.2022.04.008_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211039099","article-title":"Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: a systematic review and meta-analysis","volume":"9","author":"Yadesa","year":"2021","journal-title":"SAGE Open Med"},{"issue":"3","key":"10.1016\/j.japh.2022.04.008_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40273-021-01120-8","article-title":"Deprescribing interventions among community-dwelling older adults: a systematic review of economic evaluations","volume":"40","author":"Romano","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.japh.2022.04.008_bib46","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1590\/1413-81232021268.05672020","article-title":"Prescri\u00e7\u00e3o de medicamentos potencialmente inapropriados para idosos segundo os Crit\u00e9rios de Beers: revis\u00e3o sistem\u00e1tica [Prescribing potentially inappropriate medications for the elderly according to Beers Criteria: systematic review]","volume":"26","author":"Praxedes M.F.","year":"2021","journal-title":"Cien Saude Colet"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib47","first-page":"407","article-title":"Potentially Inappropriate Medication Use in a Medicare Managed Care Population: Association with Higher Costs and Utilization","volume":"7","author":"Fick","year":"2001","journal-title":"J\u00a0Manag Care Pharm"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1543-5946(04)90015-3","article-title":"Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly","volume":"2","author":"Aparasu","year":"2004","journal-title":"Am J Geriatr Pharmacother"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib49","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.mlr.0000254571.05722.34","article-title":"Potentially Inappropriate Medication Use and Healthcare Expenditures in the US Community-Dwelling Elderly","volume":"45","author":"Fu","year":"2007","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/nur.20232","article-title":"Health outcomes associated with potentially inappropriate medication use in older adults","volume":"31","author":"Fick","year":"2008","journal-title":"Res Nurs Health"},{"issue":"6","key":"10.1016\/j.japh.2022.04.008_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1331\/JAPhA.2009.08102","article-title":"National study of medications associated with injury in elderly Medicare\/Medicaid dual enrollees during 2003","volume":"49","author":"Blackwell","year":"2009","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.amjopharm.2010.03.005","article-title":"Potentially inappropriate medication use in elderly Japanese patients","volume":"8","author":"Akazawa","year":"2010","journal-title":"Am J Geriatr Pharmacother"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib53","first-page":"e1","article-title":"Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly","volume":"16","author":"Stockl","year":"2010","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.japh.2022.04.008_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1176\/appi.ps.201200089","article-title":"Economic Impact of Inappropriate Benzodiazepine Prescribing and Related Drug Interactions Among Elderly Persons","volume":"64","author":"Dionne","year":"2013","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jgs.13229","article-title":"Association Between Potentially Inappropriate Medication Use in Elderly Adults and Hospital-Related Outcomes","volume":"63","author":"Hagstrom","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.japh.2022.04.008_bib56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40266-015-0287-4","article-title":"Impact of Inappropriate Drug Use on Hospitalizations, Mortality, and Costs in Older Persons and Persons with Dementia: Findings from the SNAC Study","volume":"32","author":"Sk\u00f6ldunger","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.japh.2022.04.008_bib57","unstructured":"Fajreldines A.V., Insua J.T., Schnitzler E. Prescripci\u00f3n inapropiada en adultos mayores hospitalizados [Inappropriate prescription in elderly inpatients]. Medicina (B Aires). 2016:362\u2013368. [in Spanish]."},{"issue":"4","key":"10.1016\/j.japh.2022.04.008_bib58","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jgs.14030","article-title":"Effect of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Use and Cost in Individuals with Overactive Bladder","volume":"64","author":"Suehs","year":"2016","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.japh.2022.04.008_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s40266-017-0464-8","article-title":"Impact of 2015 Update to the Beers Criteria on Estimates of Prevalence and Costs Associated with Potentially Inappropriate Use of Antimuscarinics for Overactive Bladder","volume":"34","author":"Suehs","year":"2017","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10198-018-0992-0","article-title":"The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons: a longitudinal 12-year study","volume":"20","author":"Hyttinen","year":"2019","journal-title":"Eur J Heal Econ"},{"issue":"4","key":"10.1016\/j.japh.2022.04.008_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40266-017-0441-2","article-title":"Health Service Use, Costs, and Adverse Events Associated with Potentially Inappropriate Medication in Old Age in Germany: Retrospective Matched Cohort Study","volume":"34","author":"Heider","year":"2017","journal-title":"Drugs Aging"},{"issue":"7","key":"10.1016\/j.japh.2022.04.008_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198004","article-title":"The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study","volume":"13","author":"Heider","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib63","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jgo.2019.01.012","article-title":"Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers","volume":"10","author":"Feng","year":"2019","journal-title":"J\u00a0Geriatr Oncol"},{"issue":"5","key":"10.1016\/j.japh.2022.04.008_bib64","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1248\/bpb.b18-00820","article-title":"Analysis of Adverse Reactions Caused by Potentially Inappropriate Prescriptions and Related Medical Costs That Are Avoidable Using the Beers Criteria: The Japanese Version and Guidelines for Medical Treatment and Its Safety in the Elderly 2015","volume":"42","author":"Tachi","year":"2019","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"10.1016\/j.japh.2022.04.008_bib65","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3233\/JAD-190819","article-title":"Drug-Related Problems Increase Healthcare Costs for People Living with Dementia","volume":"73","author":"Wohlgemuth","year":"2020","journal-title":"J\u00a0Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.japh.2022.04.008_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s41669-019-0143-2","article-title":"The Health System Costs of Potentially Inappropriate Prescribing: A Population-Based, Retrospective Cohort Study Using Linked Health Administrative Databases in Ontario, Canada","volume":"4","author":"Black","year":"2020","journal-title":"PharmacoEconomics - Open"},{"issue":"11","key":"10.1016\/j.japh.2022.04.008_bib67","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1111\/jgs.16743","article-title":"Potentially Inappropriate Medications Are Associated with Increased Healthcare Utilization and Costs","volume":"68","author":"Clark","year":"2020","journal-title":"J\u00a0Am Geriatr Soc"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319122001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:29:48Z","timestamp":1778617788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319122001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1544319122001261"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2022.04.008","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost of adverse drug events related to potentially inappropriate medication use: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}